“I think a lot of people see [digital therapeutics] as an element of the future of healthcare, particularly in the behavioral health space,” she said in an interview withmHealthIntelligence. “We are continuing to see more and more trials in this arena as well. And so, while the...
This effort, along with others, is part of the effort to create an optimal healthcare system for Medicare beneficiaries and all Americans. CMS said they hope to transform the healthcare system to one that provides better care, spends money more wisely, and makes patient-centered care a priorit...
often insured by Medicaid and Medicare, face complex healthcare barriers that technology can address—emphasizing the role of the Center for Medicaid and Medicare Services (CMS) in fostering innovation. Dasari et al. identify four areas of CMS collaboration with ...
Consider the Evidence: CMS and DOJ at Odds Over the Role of Scientific Data in Medicare Drug Reimbursement DeterminationsJohn T. Bentivoglio
(AMA) late last year. As announced inearlierthis year, these codes may enable indirect reimbursement for digital therapeutics and similar devices by identifying the physician’s (or other qualified professional) services that will be associated with utilizing the device. This may allow digital ...
What the CMS 2025 PFS proposed rule means for virtual care The 2025 PFS proposed rule extends existing virtual care payment rules and introduces new codes for digital therapeutics, highlighting virtual care’s lasting role in healthcare. The Centers for Medicare & Medicaid Services (CMS) issued it...
Obesity is a disease that has multiple causes and consequences, not limited to weight,” Michael Kolber, JD, health care partner at Manatt, Phelps, and Phillips, LLP, said in a press briefing. “Some medical specialty groups, in fact, have advocated for the use of a...
The rule would require increased patient electronic access to their health care information and would improve the electronic exchange of health information among payers, providers, and patients. Together, these policies would play a key role in reducing overall payer and provider burden and improving ...
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals Emerging Research at SNMMI Examines 18F-Flotufolastat in Managing Primary and Recurrent Prostate Cancer Could Pluvicto Have a Role in Taxane-Naive mCRPC?: an Interview with Oliver Sartor, MD New SNMMI...
The Federal Role in Reducing Hospital-Acquired Conditions: Are Medicare Reimbursement Incentives Enough? This misguided approach could render the new CMS rule ineffectual, or worse, result in unintended consequences that undermine patient care. To significantly contribute to a reduction in hospital-acquired...